Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,314 warrant series at 1,053 companies. 775 in the money, 58 expiring in the next 30 days, 38 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Placement Agent (PA) Warrants | $0.6350 | $4.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Prior existing warrants | $0.6350 | $4.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series A-1 Warrants | $0.6350 | $4.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series A-2 Warrants | $0.6350 | $4.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| August 2025 Common Warrants | $0.7810 | $4.2M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| August 2025 Placement Agent Warrants | $0.7810 | $4.2M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| February 2025 Common Warrants | $0.7810 | $4.2M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| February 2025 PA Warrants | $0.7810 | $4.2M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| January 2024 Series A and Series B Common Warrants | $0.7810 | $4.2M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| January 2024 Warrants - unitemised remainder of 10-Q table line | $0.7810 | $4.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| July 2024 Common Warrants | $0.7810 | $4.2M | S-3/A, Aug 16, 2024Dilution tabAs of Nov 12, 2026 | ||||||||
| July 2024 Placement Agent Warrants | $0.7810 | $4.2M | S-3/A, Aug 16, 2024Dilution tabAs of Nov 12, 2026 | ||||||||
| July 2025 Common Warrants | $0.7810 | $4.2M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| July 2025 Placement Agent Warrants | $0.7810 | $4.2M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| June 2025 Placement Agent Warrants | $0.7810 | $4.2M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| June 2025 Series A Warrants | $0.7810 | $4.2M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| June 2025 Series B Warrants | $0.7810 | $4.2M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Legacy SeaStar Inc. Warrants | $0.7810 | $4.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| October 2026 Placement Agent Warrants | $0.7810 | $4.2M | 8-K, Oct 5, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| October 2026 Series A Warrants | $0.7810 | $4.2M | 8-K, Oct 5, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| October 2026 Series B Warrants | $0.7810 | $4.2M | 8-K, Oct 5, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| PIPE Investor Warrants (Unadjusted Warrants, liability-classified) | $0.7810 | $4.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Private Placement Warrants (SPAC sponsor; Unadjusted Warrants, liability-classified) | $0.7810 | $4.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Public Stockholders' Warrants (Listed Warrants, ICUCW) | $0.7810 | $4.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| 2023 Placement Agent Warrants (H.C. Wainwright designees) | $2.45 | $4.1M | 20-F, Jul 16, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| 2026 Placement Agent Warrants (January 2026 registered direct) | $2.45 | $4.1M | 20-F, Jul 16, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| GaMee completion pre-funded warrants (Animoca Brands) | $2.45 | $4.1M | 6-K, May 27, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| January 2026 registered direct pre-funded warrants | $2.45 | $4.1M | 20-F, Jul 16, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| Series C (Class C) Warrants (October 2023 private placement) | $2.45 | $4.1M | 20-F, Jul 16, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| April 2026 PIPE Pre-Funded Warrants | $0.9300 | $4.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| April 2026 PIPE Tranche A-1 Warrants | $0.9300 | $4.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| April 2026 PIPE Tranche A-2 Warrants | $0.9300 | $4.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| February 2024 PIPE Tranche A Warrants | $0.9300 | $4.1M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| February 2024 PIPE Tranche B Warrants | $0.9300 | $4.1M | 10-K, Mar 25, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Legacy Pre-Funded Warrants (February 2024 private placement, remaining) | $0.9300 | $4.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Other legacy warrants (unitemised residual) | $0.9300 | $4.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Agents' options issued January 11, 2022 | $0.1585 | $4.1M | 6-K EX-99.1, Nov 17, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Agents' options issued October 31, 2023 | $0.1585 | $4.1M | 6-K EX-99.1, Nov 17, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Pre-funded common stock purchase option issued to BSD Capital Ltd (October 3, 2025, value-guaranteed $5,600,000) | $0.1585 | $4.1M | 6-K EX-99.1, Nov 17, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Pre-funded warrants issued October 31, 2023 | $0.1585 | $4.1M | 6-K EX-99.1, Nov 17, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Warrants issued January 11, 2022 | $0.1585 | $4.1M | 6-K EX-99.1, Nov 17, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| October 2023 Placement Agent Warrants | $5.77 | $4.0M | S-3, Oct 26, 2023Dilution tabAs of Nov 3, 2026 | ||||||||
| October 2023 Private Placement Tranche A Warrants | $5.77 | $4.0M | S-3, Oct 26, 2023Dilution tabAs of Nov 3, 2026 | ||||||||
| Pre-funded warrants outstanding (aggregate, as of October 29, 2025) | $5.77 | $4.0M | 424B5, Oct 30, 2025Dilution tabAs of Nov 3, 2026 | ||||||||
| September 2024 Underwriter Warrants | $5.77 | $4.0M | 8-K, Sep 30, 2024Dilution tabAs of Nov 3, 2026 | ||||||||
| ELOC Warrant (March 20, 2025 Equity Purchase Agreement) | $0.3630 | $4.0M | 10-K, Mar 26, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Mast Hill Note Warrant (March 20, 2025 Securities Purchase Agreement) | $0.3630 | $4.0M | 10-K, Mar 26, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Warrants outstanding at December 31, 2024 (not itemised by series) | $0.3630 | $4.0M | 10-K, Mar 26, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Warrants registered for resale on Form S-3 (File No. 333-290640) — Kiront/Hiller/Alligood | $0.3630 | $4.0M | 424B3, Nov 26, 2025Dilution tabAs of Nov 14, 2026 | ||||||||
| December 2025 Warrants | $0.6122 | $4.0M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 |
AMSTAmesite Inc.$0.6350Last price
Placement Agent (PA) Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
AMSTAmesite Inc.$0.6350Last price
Prior existing warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
AMSTAmesite Inc.$0.6350Last price
Series A-1 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
AMSTAmesite Inc.$0.6350Last price
Series A-2 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
August 2025 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
August 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
February 2025 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
February 2025 PA Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
January 2024 Series A and Series B Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
January 2024 Warrants - unitemised remainder of 10-Q table line
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
July 2024 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
July 2024 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
July 2025 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
July 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
June 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
June 2025 Series A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
June 2025 Series B Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
Legacy SeaStar Inc. Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
October 2026 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
October 2026 Series A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
October 2026 Series B Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
PIPE Investor Warrants (Unadjusted Warrants, liability-classified)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
Private Placement Warrants (SPAC sponsor; Unadjusted Warrants, liability-classified)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ICUSeaStar Medical Holding Corporation$0.7810Last price
Public Stockholders' Warrants (Listed Warrants, ICUCW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.2M
ALPAlpha Compute Corp$2.45Last price
2023 Placement Agent Warrants (H.C. Wainwright designees)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
ALPAlpha Compute Corp$2.45Last price
2026 Placement Agent Warrants (January 2026 registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
ALPAlpha Compute Corp$2.45Last price
GaMee completion pre-funded warrants (Animoca Brands)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
ALPAlpha Compute Corp$2.45Last price
January 2026 registered direct pre-funded warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
ALPAlpha Compute Corp$2.45Last price
Series C (Class C) Warrants (October 2023 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
KPRXKiora Pharmaceuticals, Inc.$0.9300Last price
April 2026 PIPE Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
KPRXKiora Pharmaceuticals, Inc.$0.9300Last price
April 2026 PIPE Tranche A-1 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
KPRXKiora Pharmaceuticals, Inc.$0.9300Last price
April 2026 PIPE Tranche A-2 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
KPRXKiora Pharmaceuticals, Inc.$0.9300Last price
February 2024 PIPE Tranche A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
KPRXKiora Pharmaceuticals, Inc.$0.9300Last price
February 2024 PIPE Tranche B Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
KPRXKiora Pharmaceuticals, Inc.$0.9300Last price
Legacy Pre-Funded Warrants (February 2024 private placement, remaining)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
KPRXKiora Pharmaceuticals, Inc.$0.9300Last price
Other legacy warrants (unitemised residual)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
CHAICore AI Holdings Inc$0.1585Last price
Agents' options issued January 11, 2022
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
CHAICore AI Holdings Inc$0.1585Last price
Agents' options issued October 31, 2023
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
CHAICore AI Holdings Inc$0.1585Last price
Pre-funded common stock purchase option issued to BSD Capital Ltd (October 3, 2025, value-guaranteed $5,600,000)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
CHAICore AI Holdings Inc$0.1585Last price
Pre-funded warrants issued October 31, 2023
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
CHAICore AI Holdings Inc$0.1585Last price
Warrants issued January 11, 2022
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.1M
NVNOenVVeno Medical Corporation$5.77Last price
October 2023 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.0M
NVNOenVVeno Medical Corporation$5.77Last price
October 2023 Private Placement Tranche A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.0M
NVNOenVVeno Medical Corporation$5.77Last price
Pre-funded warrants outstanding (aggregate, as of October 29, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.0M
NVNOenVVeno Medical Corporation$5.77Last price
September 2024 Underwriter Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.0M
CWDCaliberCos Inc.$0.3630Last price
ELOC Warrant (March 20, 2025 Equity Purchase Agreement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.0M
CWDCaliberCos Inc.$0.3630Last price
Mast Hill Note Warrant (March 20, 2025 Securities Purchase Agreement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.0M
CWDCaliberCos Inc.$0.3630Last price
Warrants outstanding at December 31, 2024 (not itemised by series)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.0M
CWDCaliberCos Inc.$0.3630Last price
Warrants registered for resale on Form S-3 (File No. 333-290640) — Kiront/Hiller/Alligood
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.0M
IMNNImunon, Inc.$0.6122Last price
December 2025 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.0M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,065 dilution snapshots. 4,861 of 5,314 series state an exercise price and 3,366 an expiry date. 154 record when exercise begins; that count grows as companies are re-extracted. 623 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.